6
Aug 2026
Scientists combine imaging and phototherapy in a single tool against glioblastoma
Glioblastoma is the most aggressive form of brain cancer.
Stay Informed!
5
Aug 2026
Cortisol may distort the body signals that guide risky choices in men
In a randomized study of 109 young adults, researchers measured cortisol responses, skin conductance signals, and risk-taking during the Iowa Gambling Task after an acute psychosocial stressor. Cortisol reactivity altered how anticipatory bodily signals related to risky choices in men, although the stress condition did not increase overall risk-taking.
5
Aug 2026
GLP-1 drug tirzepatide associated with lower risk of major cardiovascular events
Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds a study published by The BMJ today.
5
Aug 2026
Study reveals treatment gaps for atypical Alzheimer's disease patients
Many people with less common forms of Alzheimer's disease may not qualify for newer anti-amyloid treatments designed to slow the disease, according to a study published August 5, 2026, in Neurology®, the medical journal of the American Academy of Neurology.
5
Aug 2026
NIH funds Boston University center for Alzheimer's prevention studies
Maria Glymour, Andrew Stokes, and Deborah Carr will lead the Boston University-Quantitative Population Science and Healthy Cognitive Aging Research Program (BU-SHARP) to foster national research collaboration on preventing and ameliorating the consequences of Alzheimer's disease and related dementias in disproportionately affected populations.
5
Aug 2026
Long-acting HIV prevention tools could help close the gap before a vaccine arrives
A review of non-vaccine HIV interventions highlights the strong preventive effects of long-acting PrEP, sustained ART, U=U, vertical transmission programs, and voluntary medical male circumcision. Gene editing and multispecific antibodies may expand future options, but safety, cost, access, adherence, and implementation barriers remain.
5
Aug 2026
ACLM launches first lifestyle medicine evidence repository for healthcare professionals
The American College of Lifestyle Medicine (ACLM) has launched the Lifestyle Medicine Evidence Repository, the first centralized, curated collection of scientific research focused specifically on lifestyle medicine interventions.
5
Aug 2026
Neural stem cells split early into distinct neuron lineages
The cerebral cortex is densely packed with different nerve cells that enable us to perceive, think and act. Yet how these cell types arise while the brain develops is still not fully understood.
5
Aug 2026
AI tool aims to accelerate Alzheimer's treatment through faster referrals
Vanderbilt Health researchers have received a grant from Eli Lilly and Company, a multinational pharmaceutical company headquartered in Indianapolis, to build an artificial intelligence (AI) tool within the electronic health record system (EHR) to get patients with Alzheimer's disease to treatment faster.
5
Aug 2026
International team builds comprehensive cancer models for future drug development
To develop new targeted treatments for cancer, scientists need tissue models that accurately represent the genetic and molecular traits of the cancer they're studying.
